One of the hardest parts of depression is not just feeling bad. It’s feeling bad after trying to get better.
You try therapy. You try medication. You wait weeks for improvement, and maybe something helps briefly. Maybe nothing changes much at all.
After a while, many people begin asking the same question: “What if nothing works for me?”
That feeling is common in treatment-resistant depression. It’s also one reason ketamine therapy has drawn so much attention over the last several years. Not because it’s magic, but because it works through a fundamentally different pathway than traditional antidepressants.
And for some patients, that difference matters.
Most common antidepressants—such as SSRIs and SNRIs—primarily work by affecting serotonin or norepinephrine levels in the brain.
For many people, these medications are helpful. They reduce symptoms, improve stability, and create enough relief to make therapy and daily life more manageable.
But not everyone responds that way.
About 30% of people with depression develop what’s known as treatment-resistant depression, meaning they don’t experience adequate relief after trying multiple antidepressants.
That doesn’t mean they failed treatment, despite how patients might feel, despite how the diagnosis may further entrench symptoms. It may mean the brain systems driving their depression are more complicated than serotonin alone.
The older explanation of depression as simply a serotonin deficiency is incomplete.
Researchers now understand depression as involving broader disruptions in brain communication, stress response, emotional regulation, and neuroplasticity.
Over time, depression can reinforce rigid patterns:
The brain becomes less flexible and more “stuck.”
That’s part of why some people feel like they’re trapped in the same mental loops no matter how hard they try to think differently.
Ketamine affects the brain’s glutamate system, which plays a major role in how neurons communicate and form connections.
Rather than gradually adjusting serotonin levels over several weeks, ketamine appears to rapidly increase neuroplasticity, which is the brain’s ability to reorganize and form new neural pathways.
In practical terms, patients often describe:
With ketamine, the brain may temporarily become more flexible and less locked into rigid depressive patterns. For many people, that shift creates enough space to begin engaging with life differently again.
A recent study published in the Journal of Clinical Psychiatry examined more than 300 patients receiving ketamine or esketamine treatment for treatment-resistant depression.
Researchers found that outcomes did not significantly differ based on whether patients were taking SSRIs, SNRIs, other antidepressants, or no antidepressants during treatment.
That’s important because it suggests ketamine’s antidepressant effects may operate independently from the traditional serotonin-based pathways targeted by many medications.
In other words: Even when standard antidepressants hadn’t produced enough relief, ketamine still helped many patients improve.
People with treatment-resistant depression often carry a quiet fear: “If medications haven’t worked by now, maybe nothing will.”
But different treatments target different systems.
A lack of response to one pathway does not mean the brain is incapable of healing. It may simply mean a different biological approach is needed.
That’s part of why ketamine has become such an important option in psychiatry. It offers another route forward when the traditional route hasn’t been enough.
Ketamine is not a cure. And it’s not meant to replace therapy, lifestyle changes, or ongoing psychiatric care.
But for some patients, it creates a critical shift:
Sometimes that’s where recovery begins.
Depression treatments can stop working—or never work fully—for many reasons. That doesn’t mean improvement is impossible.
Ketamine is different because it works through different brain systems tied to neuroplasticity and neural communication. Recent research suggests those effects occur regardless of whether patients are taking traditional antidepressants alongside treatment.
For patients who feel stuck after years of trying to get better, that difference may open a door that previously felt closed.
